Logo image of EQS.DE

EQS GROUP AG (EQS.DE) Stock Fundamental Analysis

FRA:EQS - Deutsche Boerse Ag - DE0005494165 - Common Stock - Currency: EUR

39.8  -0.3 (-0.75%)

Fundamental Rating

3

Taking everything into account, EQS scores 3 out of 10 in our fundamental rating. EQS was compared to 98 industry peers in the Software industry. EQS may be in some trouble as it scores bad on both profitability and health. EQS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EQS has reported negative net income.
EQS had a positive operating cash flow in the past year.
EQS had negative earnings in 4 of the past 5 years.
Each year in the past 5 years EQS had a positive operating cash flow.
EQS.DE Yearly Net Income VS EBIT VS OCF VS FCFEQS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 2M -2M 4M -4M -6M

1.2 Ratios

EQS has a Return On Assets of -1.58%. This is in the lower half of the industry: EQS underperforms 66.28% of its industry peers.
Looking at the Return On Equity, with a value of -2.65%, EQS is doing worse than 63.95% of the companies in the same industry.
Industry RankSector Rank
ROA -1.58%
ROE -2.65%
ROIC N/A
ROA(3y)-2.29%
ROA(5y)-1.68%
ROE(3y)-5.02%
ROE(5y)-3.7%
ROIC(3y)N/A
ROIC(5y)N/A
EQS.DE Yearly ROA, ROE, ROICEQS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 5 -5

1.3 Margins

EQS's Gross Margin of 29.45% is on the low side compared to the rest of the industry. EQS is outperformed by 84.88% of its industry peers.
EQS's Gross Margin has declined in the last couple of years.
EQS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-4.64%
EQS.DE Yearly Profit, Operating, Gross MarginsEQS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30

More info and screens

3

2. Health

2.1 Basic Checks

EQS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EQS has been increased compared to 1 year ago.
EQS has a better debt/assets ratio than last year.
EQS.DE Yearly Shares OutstandingEQS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M
EQS.DE Yearly Total Debt VS Total AssetsEQS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.39 indicates that EQS is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.39, EQS is in line with its industry, outperforming 58.14% of the companies in the same industry.
The Debt to FCF ratio of EQS is 5.21, which is a neutral value as it means it would take EQS, 5.21 years of fcf income to pay off all of its debts.
EQS has a Debt to FCF ratio of 5.21. This is comparable to the rest of the industry: EQS outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that EQS is not too dependend on debt financing.
EQS has a Debt to Equity ratio of 0.22. This is comparable to the rest of the industry: EQS outperforms 56.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 5.21
Altman-Z 3.39
ROIC/WACCN/A
WACC6.32%
EQS.DE Yearly LT Debt VS Equity VS FCFEQS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 20M 40M 60M 80M 100M

2.3 Liquidity

EQS has a Current Ratio of 0.59. This is a bad value and indicates that EQS is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of EQS (0.59) is worse than 91.86% of its industry peers.
EQS has a Quick Ratio of 0.59. This is a bad value and indicates that EQS is not financially healthy enough and could expect problems in meeting its short term obligations.
EQS has a Quick ratio of 0.59. This is amonst the worse of the industry: EQS underperforms 91.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
EQS.DE Yearly Current Assets VS Current LiabilitesEQS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 58.49% over the past year.
EQS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.43%.
The Revenue has been growing by 15.14% on average over the past years. This is quite good.
EPS 1Y (TTM)58.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.22%
Revenue 1Y (TTM)12.43%
Revenue growth 3Y20.2%
Revenue growth 5Y15.14%
Sales Q2Q%12.42%

3.2 Future

EQS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.20% yearly.
The Revenue is expected to grow by 18.96% on average over the next years. This is quite good.
EPS Next Y84.44%
EPS Next 2Y85.23%
EPS Next 3Y71.2%
EPS Next 5YN/A
Revenue Next Year17.52%
Revenue Next 2Y19.35%
Revenue Next 3Y18.96%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EQS.DE Yearly Revenue VS EstimatesEQS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
EQS.DE Yearly EPS VS EstimatesEQS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

EQS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 85.67 indicates a quite expensive valuation of EQS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EQS indicates a slightly more expensive valuation: EQS is more expensive than 67.44% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (35.78), we can say EQS is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 85.67
EQS.DE Price Earnings VS Forward Price EarningsEQS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

EQS's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. EQS is more expensive than 69.77% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 59.58
EV/EBITDA 56.51
EQS.DE Per share dataEQS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

EQS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EQS's earnings are expected to grow with 71.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.23%
EPS Next 3Y71.2%

More info and screens

0

5. Dividend

5.1 Amount

EQS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EQS GROUP AG

FRA:EQS (4/10/2024, 7:00:00 PM)

39.8

-0.3 (-0.75%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap398.92M
Analysts50
Price Target39.53 (-0.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.1
Dividend Growth(5Y)-6.86%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)46.05%
EPS NY rev (3m)-136.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.56%
Revenue NY rev (3m)0.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 85.67
P/S 5.93
P/FCF 59.58
P/OCF 43.93
P/B 3.6
P/tB N/A
EV/EBITDA 56.51
EPS(TTM)-0.29
EYN/A
EPS(NY)0.46
Fwd EY1.17%
FCF(TTM)0.67
FCFY1.68%
OCF(TTM)0.91
OCFY2.28%
SpS6.71
BVpS11.05
TBVpS-4.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -2.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.45%
FCFM 9.96%
ROA(3y)-2.29%
ROA(5y)-1.68%
ROE(3y)-5.02%
ROE(5y)-3.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-4.64%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 5.21
Debt/EBITDA 3.25
Cap/Depr 29.87%
Cap/Sales 3.55%
Interest Coverage N/A
Cash Conversion 121.37%
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 3.39
F-Score7
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)40.83%
Cap/Depr(5y)81.49%
Cap/Sales(3y)5.4%
Cap/Sales(5y)8.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)58.49%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.22%
EPS Next Y84.44%
EPS Next 2Y85.23%
EPS Next 3Y71.2%
EPS Next 5YN/A
Revenue 1Y (TTM)12.43%
Revenue growth 3Y20.2%
Revenue growth 5Y15.14%
Sales Q2Q%12.42%
Revenue Next Year17.52%
Revenue Next 2Y19.35%
Revenue Next 3Y18.96%
Revenue Next 5YN/A
EBIT growth 1Y91.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year441%
EBIT Next 3Y119.66%
EBIT Next 5YN/A
FCF growth 1Y685.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y445.35%
OCF growth 3Y31.24%
OCF growth 5Y26.88%